
Marketing the Medical Patent Before the FDA “Green Light”: Really?
June 10, 2026
What is the Probability of a Newcomer Getting FDA Clearance?
June 17, 2026Medical Patents Broker Inc.
By Kenneth Pearce, President
Do We Need Product Recall Insurance? Unless You Are Self-Insured, You Better Believe It!
The longer a company manufactures a medical invention, the greater the probability that a microgram of a foreign substance or a single line of code will force a recall. This can happen despite double-checking every lot, batch, or line. While digital controls are fantastic for reducing errors, they are not infallible. To err is human; a glitch in a manufacturing program can result in too many—or too few—active medical components. Then, there are the contaminants that can infiltrate a facility at any time.
The Domino Effect of an FDA Recall:
- Logistics & Disposal: The cost of physical retrieval, secure storage, and the environmentally safe destruction of bio-hazardous or electronic medical waste.
- Notification Costs: The massive undertaking of reaching every hospital, clinic, and patient in your distribution chain.
- Business Interruption: Compensation for lost profits during the period when your production line is halted for remediation.
- Crisis Management: Access to specialized PR firms to mitigate “brand bleed.” While PR can help, a brand may never return to its former pristine state.
- Replacement & Refunding: The immediate capital required to provide functional replacements or full refunds to end-users.
- Potential Class Action Suits: If there are injuries, the sky is the limit for legal fees and settlements.
- The Component Rider: If you manufacture a subsystem that is part of a larger medical device, the parent company will likely transfer liability to you the moment your component is identified as the culprit.
Survival is a Numbers Game
For most manufacturers, securing insurance for recalls—whether initiated by the FDA or the company—is a straightforward necessity:
- Audit Your Policy: Check your General Liability coverage. Most standard policies offer little to no protection for the actual costs of a recall.
- The “Company Killer”: A nationwide recall can bankrupt a company, permanently depriving patients of your medical invention.
- Exit Strategy Risk: The option to sell or license the medical patents—the legal foundation of your invention—is likely shuttered once a recall hits.
- Mandatory vs. Voluntary: Ensure your policy triggers for both FDA-ordered and self-initiated recalls.
- The Deductible Factor: Ensure you have the liquid capital to cover the deductible. Total costs almost always exceed initial estimates.
- The Bankruptcy Threshold: Without insurance, a recall may require Chapter 7 or Chapter 11. Either way, it’s “goodbye” to your investors.
Close Calls: The Recalls That Never Happened
No one knows how many substandard products have entered the medical system without reported side effects or deficient treatments. No awareness, no recall. But relying on "not getting caught" is not a business strategy; it's a gamble with your life's work.
The President’s Viewpoint
Because medical inventions carry higher stakes than almost any other product, the cost of protection must be baked into the business plan. We hope it is never required, but Product Recall Insurance is the asset that saves the company when things go wrong.
A Personal Note: For years, I have taken pantoprazole. The tablets in my most recent bottle failed to stop the heartburn. I took a few remaining tablets from a previous prescription, and the heartburn stopped immediately. My conclusion? The recent batch was sub-potent. While I won’t let my heartburn cause “heartache” for the generic manufacturer this time, it is a stark reminder of how easily a batch can fail. In the medical world, sub-potency isn't just an inconvenience—it's a liability waiting to happen.




